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Abstract
α-synuclein (α-syn) is a major component of the intracellular inclusions called Lewy bodies,
which are a key pathological feature in the brains of Parkinson’s disease patients. The neuro-
transmitter dopamine (DA) inhibits the fibrillisation of α-syn into amyloid, and promotes α-syn
aggregation into SDS-stable soluble oligomers. While this inhibition of amyloid formation re-
quires the oxidation of both DA and themethionines in α-syn, the molecular basis for these
processes is still unclear. This study sought to define the protein sequences required for the
generation of oligomers.We tested N- (α-syn residues 43–140) and C-terminally (1–95) truncat-
ed α-syn, and found that similar to full-length protein both truncated species formed soluble DA:
α-syn oligomers, albeit 1–95 had a different profile. Using nuclear magnetic resonance (NMR),
and the N-terminally truncated α-syn 43–140 protein, we analysed the structural characteristics
of the DA:α-syn 43–140 dimer and α-syn 43–140monomer and found the dimerisation interface
encompassed residues 43 to 60. Narrowing the interface to this small region will help define the
mechanism by which DAmediates the formation of SDS-stable soluble DA:α-syn oligomers.
INTRODUCTION
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by severe
motor dysfunction, muscular rigidity and resting tremor. [1] Pathologically, PD is character-
ised by the presence of intracellular protein inclusions: Lewy bodies in the neuronal cell bodies
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and Lewy neurites in the neuronal processes. [2] A major constituent of the Lewy body and
Lewy neurites is the α-synuclein (α-syn) protein. α-syn aggregates, over time, into amyloido-
genic fibrils and this can be modulated by a range of factors including protein concentration,
anions, pesticides, metals, neurochemicals and proteins. [3, 4] α-syn is an intrinsically disor-
dered protein (IDP) comprising 140 amino acids. It contains three regions with distinct struc-
tural characteristics: the N-terminus encompassing residues 1–60 contains a series of imperfect
repeats with a consensus motif of KTKEGV, residues 61–95 encoding the non-amyloid β com-
ponent of the Alzheimer’s disease amyloid (NAC) forms the amyloidogenic core of α-syn,
and the C-terminus encompassing residues 96–140 which is a highly negatively charged region.
[5, 6]
The loss of dopaminergic neurons in the substantia nigra, and the subsequent depletion of
dopamine (DA) in the striatum is a key feature of PD. α-syn expression can regulate DA me-
tabolism since α-syn knockout mice have reduced striatal DA levels and an attenuated DA-de-
pendent locomotor response to amphetamine. [7] There is an important interaction between
DA and α-syn resulting in DA (and related catecholamines) inhibiting α-syn fibrillisation into
amyloid [8–15] and inducing the formation of SDS-stable soluble oligomers. [8, 13, 16] The in-
teraction of DA with α-syn results in the oxidation of all four methionine residues in α-syn, a
process necessary for the formation of the soluble α-syn oligomers. [17, 18] The catechol medi-
ated aggregation of α-syn also requires their oxidation [10, 12, 19] and can involve the interac-
tion of the oxidised catechols with the YEMPS sequence in the C-terminal region of α-syn. [12]
DA oxidation is a complex process resulting in diverse metabolites with different properties
and that can either have toxic or protective effects [20]). An oxidative metabolite of DA is do-
pamine quinone and this forms covalent adducts with α-syn to yield soluble oligomers. [10, 16,
21] While the nature of the DA linkage to α-syn is still ill-defined, the DA:α-syn oligomers are
highly stable and remain intact even in the presence of strong denaturants such as 6 M guani-
dine hydrochloride or urea. [22] Formation of DA:α-syn oligomers can be modulated by pH
and lipids. [19] Lipids inhibit the formation of the DA-induced α-syn oligomers [23] while the
DA metabolite 5,6-dihydroxylindole promotes soluble α-syn oligomer formation at physiologi-
cal pH, but under alkaline conditions gives to insoluble oligomers. [19]
There is a clear difference in behaviour between α-syn and the DA:α-syn oligomer since the
DA:α-syn oligomer cannot interact with lipid vesicles or cause membrane permeability while
α-syn (in the absence of DA) does. [23] While DA-induced α-syn oligomers are detectable in
cells [8, 14, 15], it is unclear if they represent toxic [11, 14] or non-toxic [8, 15] species. Their
role in cells may relate to a proposed function in modulating energy metabolism, oxidative
stress and proteostasis. [3]
Structural analysis using atomic force microscopy indicated the DA:α-syn oligomers pos-
sessed non-fibrillar morphologies. [12, 24] Electrospray-ionisation-ion mobility spectrometry-
mass spectrometry (ESI-IMS-MS) [25] and small angle X-ray scattering (SAXS) [22, 26]
showed DA binds to α-syn when the protein is in an extended conformation. Single-molecule
photobleaching and substoichiometric fluorescent labeling determined that DA:α-syn aggre-
gates form as two distinct species a minor assembly containing 15–19 monomers and a major
assembly of 34–38 monomers. [27] However, smaller oligomeric assemblies are also present in
solution since dimeric to tridecamer DA:α-syn species have been fractionated by size exclusion
chromatography (SEC). [24, 26] Nuclear magnetic resonance (NMR) and molecular dynamic
stimulations suggested the N-terminal imperfect repeats and glutamate 83 in the NAC domain
are necessary for interactions with DA. [28] To understand the nature of the interaction be-
tween DA and α-syn we have investigated which regions of α-syn are required for the forma-
tion of the DA-mediated oligomers. We used an N-terminal truncated dimeric species of α-
syn, encoding residues 43–140, for detailed structural and biophysical analysis. We identified
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the region between residues 43 to 60 to contain residues necessary for DA mediated dimerisa-
tion of α-syn.
Experimental Procedures
Production of α-syn
Full-length (1–140) human α-syn cDNA sequence was cloned into the vector pRSETB (Invi-
trogen, Carlsbad, CA) and expressed and purified as previously described. [17] Purified α-syn
fractions were pooled, dialysed against water and lyophilised. Protein identity was confirmed
by mass spectrometry. Different batches of the protein were expressed and purified during
this study.
The α-syn 1–60, 1–95, 43–140, H50N, T75P constructs were made using the QuikChange
Site Directed Mutagenesis system (Invitrogen, Carlsbad, CA). α-syn 1–60 was also produced
synthetically using FMOC peptide synthesis (Applied Biosystems, Foster City, CA). The α-syn
43–140 construct has a Met as the first residue. All truncated and mutant α-syn proteins except
α-syn 1–60 and 1–95 were expressed and purified as for wildtype α-syn above. The α-syn 1–60
and 1–95 proteins were purified by ammonium sulfate (50%) precipitation, whereby solid am-
monium sulphate was added to the lysed cell mixture (v/v) and stirred overnight at 4°C. Fol-
lowing centrifugation at 3200 × g for 1 hour at 4°C, the supernatant discarded and the pellet
resuspended in 10 mM sodium phosphate buffer pH 7.5. After boiling for 20 mins and centri-
fugation at 3200 × g for 1 hour at 4°C the supernatant was collected. The supernatant was de-
salted using a PD-10 desalting column (GE Healthcare, NSW, Australia) and then loaded on a
HiTrap SP Sepharose FF cation exchange column. Bound α-syn 1–60 and 1–95 were eluted
using a linear salt gradient from 0 to 1MNaCl in 20 mM Tris HCl at pH 8.5. Fractions contain-
ing α-syn 1–60 and 1–95 were pooled and lyophilised. The sample was resuspended in 100 mM
ammonium bicarbonate pH 7.5 and loaded onto a Sephacryl 300 SEC column (Amersham Bio-
sciences, Castle Hill, Australia) and eluted isocratically with 100 mM ammonium bicarbonate
(pH 7.5) at a flow rate of 1mL/min. α-syn 1–60 containing fractions were pooled, dialysed and
lyophilised. Protein identities were confirmed by mass spectrometry. The α-syn 43–60 peptide
was synthesised using FMOC peptide synthesis (Applied Biosystems, Foster City, CA)
Minimal media expression of α-syn
α-syn was isotopically labelled either singly (15N) or doubly (15N, 13C) for NMR studies. [29]
An overnight culture was inoculated into 2 L of LB media. When an A600 of ~0.6 was achieved,
the cells were pelleted by centrifugation at 3200 × g for 15 minutes at 4°C. Cells were washed
twice, centrifuging after each wash with M9 minimal media to remove contaminating LB
media. Cells were resuspended in M9 minimal media containing either 15NH4Cl or
15NH4Cl
and 13C glucose and allowed to equilibrate at 37°C shaking at 220 rpm for 2 hours. Expression
was induced with 1 mM IPTG overnight at 37°C. Cells were harvested by centrifugation at
3200 × g, 1 hour at 4°C. Cell pellets were stored at -20°C until lysis and purification were per-
formed according to the method outlined above. Different batches of the protein being express-
ed and purified during this study.
α-syn stock solutions
α-syn stock solutions were made up to 1mg/mL in water, and filtered through a 0.2μm pore
filter to remove preformed aggregates (0.2μmMinisart RC4 filters, Sartorius, Goettingen, Ger-
many). The concentration of stock solutions were determined by UV absorbance measure-
ments using an extinction coefficient of 5120M-1 cm-1 at λ = 280nm.
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SDS-PAGE electrophoreses
Samples were prepared in SDS sample buffer (containing 4% SDS, 20% glycerol, 0.1% Bromo-
phenol Blue, 50 mM Tris-HCl pH 6.8 and 10% β-mercaptoethanol) (v/v) and heated at 100°C
for 10 minutes. The samples, unless otherwise stated, were separated on a 12% Bis-tris SDS-
PAGE gel (Life Technologies) and the proteins visualised by silver staining according to manu-
facturer’s instructions (Bio Rad). Some samples were analysed on a Novex 16% Tricine SDS-
PAGE gel (Life Technologies) according to the manufacturer’s instructions.
Preparation of oxidised dopamine.
Oxidised DA was generated by incubating 2mMDA in PBS pH 7.4 at 30°C and shaking for 28
days. The reaction was then centrifuged at 200,000 × rpm for 60 min to obtain a pellet (insolu-
ble oxidised DA corresponding to polymerised oxidised DA) and a supernatant (soluble oxi-
dised DA) fraction. The pellet fraction was washed 3× with water and resuspended in the
original volume with water. The supernatant fractions were analysed by ESI-MS and an UV-
visible absorbance spectrum acquired between 200–700nm confirmed the absence of un-oxi-
dised DA in the sample.
Formation of DA-mediated α-syn soluble oligomers
DAmediated α-syn oligomerisation was performed as previously described [17] using 20 μM
α-syn in 10 mM phosphate buffer pH 7.4 incubated with 200 μMDA at 37°C for 18 hours,
unless otherwise stated. To analyse the soluble species the samples were transferred to polycar-
bonate tubes (7 × 20 mm polycarbonate tubes, Beckman Coulter, Fullerton, CA) and centri-
fuged at 100,000 x rpm for 1 hour at 4°C (TL-100 ultracentrifuge, Beckman Coulter).
Supernatants were collected for further analysis.
Purification of α-syn 43–140 oligomers for NMR analysis
Oligomerisation of α-syn for NMR analysis was performed by incubating 15mg of α-syn 43–140
at a concentration of 200 μMwith 2 mMDA at 37°C on a heat block for 7 days to ensure maxi-
mal oligomerisation had occurred. After 7 days, the mixture was centrifuged 100,000 × rpm for 1
hour at 4°C and the supernatant collected. The supernatant of the crude reaction mixture was
loaded onto a Superdex 200 16/60 GL SEC column (GE Healthcare, NSW, Australia). Fractions
were eluted in 10 mM sodium phosphate pH7.5. Monomer and dimer-containing fractions were
pooled and concentrated using an Amicon centrifugal unit with a molecular cut-off (MWCO) of
10 kDa. The monomer was concentrated using a unit with a 3 kDaMWCO. Different batches of
the oligomers were generated and purified during this study.
Circular Dichroism Spectroscopy
Circular dichroism (CD) measurements were performed on a JASCO 815 CD spectrometer
(Tokyo, Japan), using the Jasco software. Far UV-CD spectra were collected between 180–250 nm
at 37°C. Measurements were recorded at 50 nm/min with a 1 nm bandwidth and a 2s response
time, averaging 3 accumulation scans per measurement. All spectra were background subtracted,
and smoothed with the default algorithm in the Jasco software. Experiments were performed
in triplicate.
NMR spectroscopy
NMR spectra were acquired on a Bruker-Biospin Avance 800MHz spectrometer equipped with
a cryogenically cooled probe. All experiments were performed at 5°C, and samples were
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typically 0.5mM protein in 0.5mL 10mM phosphate buffer pH 5.5 with either 10% D2O/90%
H2O or 100% D2O as appropriate.
1H,13C-HSQC spectra were acquired on α-syn, at natural
abundance. All double-resonance spectra were acquired with 2048 complex data points in the
directly detected dimension and 512 complex data points in the indirect dimension.
A series of standard two-dimensional (2D) and three-dimensional (3D) spectra were re-
corded to obtain sequence specific assignments, these included 1H, 15NNOESY-HSQC with a
mixing time of 100 ms, 1H, 1H NOESY with a mixing time of 300 ms, 1H TOCSY with a mix-
ing time of 50 ms, 1H, 15N-HSQC, 1H, 13C-HSQC, HNCO, HN(CA)CO, HN(CO)CA, HNCA,
HNCACB, CC(CO)NH, HNHA, and HNHB. [30] The WATERGATE method was used to
suppress the solvent signal. [31]Spectra were referenced to internal DSS. All NMR data was
processed using the software TOPSPIN (Bruker Biospin AG) and analysed using the CARA ap-
plication (Rochus Keller and Kurt Wuthrich, CARA, Institute of Molecular Biology and Bio-
physics, ETH Zurich.CARA cara.nmr.ch). [32]
A 120 ms 1H,15N X-filtered NOESY-HSQC experiment were performed using sample pre-
pared by incubating α-syn in a reaction containing 50% unlabelled α-syn and 50% 13C, 15N la-
belled α-syn with DA in a 1:10 protein to DA ratio. This reaction was mixed and incubated at
37°C for 7 days. The solution was then centrifuged 100,000 × rpm, 1 hour at 4°C and the super-
natant was then separated by SEC on a Superdex 200 16/60 column (GE Healthcare, NSW,
Australia) to isolate the dimer. The dimer fractions were eluted in 10 mM sodium phosphate
buffer at pH 7.5 and concentrated using an Amicon centrifugal filter unit (Millipore, NSW,
Australia) with a MWCO of 10 kDa to a final volume of ~500μl.
Trypsin digestion
Sequencing grade trypsin (Promega, Madison, WI) was added to a solution containing either
α-syn 43–140 monomer or α-syn 43–140 dimer in 50 mM Tris-HCl pH 7.5 at a 1:50 trypsin to
protein ratio. Typically, 1mg of protein and 20 μg of trypsin was used in each experiment. The
reaction was incubated at 37°C for 18 hours and analysed using reverse phase HPLC and ESI-
TOF-MS.
Electrospray-ionisation-ion mobility spectrometry-mass spectrometry
(ESI-IMS-MS)
ESI-IMS-MS was performed as described. [25] All reagents were purchased from Sigma-Al-
drich, UK. Protein samples for ESI-IMS-MS experiments were prepared by dissolving α-syn to
a 40 μM final concentration and by diluting DA to a final concentration of 6.25 mM in aqueous
50 mM ammonium acetate pH 6.8. All spectra were acquired using a Synapt G2 HDMS instru-
ment (Manchester, Waters, UK) by use of gold coated home-made borosilicate nano-capillaries
in positive mode. Optimised instrumental settings for data acquisition were: capillary voltage
of 1.70–1.90 kV, cone voltage of 50 V, source temperature of 60°C, trap collision energy of 4.0 V,
transfer collision energy of 10 V, trap bias 45, backing pressure of 3.1 mbar. IMS separations
were performed at T-wave velocities of Trap:311, IMS:800 and Transfer:200 m/s and T-wave am-
plitudes of 4–15 V using 3.6 mbar pressure of nitrogen gas maintained by a 90 mL/min gas flow.
Mass calibration was carried out by an infusion of CsI cluster ions, and arrival time distributions
were determined by using the Mass Lynx v4.1 software (Waters, UK).
Experimental replicates
Aggregation and spectroscopy experiments were repeated at least three separate times and
were performed with different batches of expressed and purified protein and different batches
of purified oligomers.
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Results
N-terminally truncated α-syn 43–140 forms DA-mediated soluble
oligomers
To define which regions of α-syn are required for the formation of the DA-mediated soluble
oligomers, we tested N- and C-terminal truncated proteins (Fig. 1A). α-syn 43–140 lacks the
first three imperfect repeats of the consensus motif KTKEGVT, with the truncation occurring
at the break between the two α-helices in the N-terminus. [33] In α-syn 1–95 the C-terminus
was deleted just after the end of the hydrophobic NAC fragment. α-syn 1–95 or α-syn 43–140
(20 μM) were incubated with DA (200 μM) at 37°C for 18 hours, then centrifuged at 100,000 rpm
for 1 hour at 4°C and the supernatants recovered and analysed by SDS-PAGE and silver staining.
Both α-syn 1–95 and α-syn 43–140 formed DA-mediated soluble oligomeric species (Fig. 1B).
α-syn 43–140 species that have been reacted with DA are termed DA:α-syn, The profile for α-syn
Fig 1. Oligomerisation of α-syn on treatment with DA. A. Schematic of the different α-syn constructs used in this study. The black bars represent the
imperfect repeats (residues 10–16, 21–27, 32–37, 43–49, 57–63, 80–86). NAC region (stippled bar, residues 60–95). B. Silver stain SDS-PAGE gel of
truncated α-syn incubated in the presence or absence of DA. Lane 1: α-syn 1–140. Lane 2: α-syn 1–140 + DA. Lane 3: α-syn 1–95. Lane 4: α-syn 1–95 + DA.
Lane 5: α-syn 43–140. Lane 6: α-syn 43–140 + DA. The α-syn to DA ratio was 1:10.C. Size exclusion chromatography of DA:α-syn 43–140 and DA:α-syn
1–95 oligomers. 200 μM α-syn was incubated with 2 mM DA for 7 days. The reaction was centrifuged at 100,000 rpm, 1 hour, 4°C and then analysed on a
Superdex 200 10/300GL column using 10 mM sodium phosphate pH 7.5 buffer with a flow rate of 0.5 mL/min. Proteins were detected at A280nm.
doi:10.1371/journal.pone.0116497.g001
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43–140 was similar to full length α-syn, while α-syn 1–95 generated a smear like pattern on SDS-
PAGE following incubation with DA (Fig. 1B). The band migrating with the 28 kDamarker is the
DA:α-syn 43–140 dimer, and this was subsequently confirmed by SEC (Fig. 2). We also analysed
DA:α-syn 1–95 and DA:α-syn 43–140 by SEC and the migration properties of these species dem-
onstrated DA:α-syn 1–95 and DA:α-syn 43–140 had distinct elution profiles. The DA polymers
and salts eluted with the two peaks seen in the 15–20mL fractions. In the SEC chromatograms
DA:α-syn 43–140 displayed multiple bands between 5–15 mL while DA:α-syn 1–95 showed only
a single major peak and lacked distinct species in the region between 10–15 mL in the elution pro-
file (Fig. 1C). These data are consistent with the SDS-PAGE results where DA:α-syn 43–140 dis-
played distinct oligomeric species while DA:α-syn 1–95 migrated as a smear without intermediate
lower mass oligomeric species. We can conclude that while the N- and C-terminal sequences are
not critical for the formation of DA-mediated soluble oligomers the C-terminus can influence the
oligomeric profile and their behaviour. The data suggests the essential region required for forma-
tion of soluble oligomers lies in the region 43–95.
The generation of DA mediated α-syn oligomerisation requires oxidation of DA to occur
[10] and it is the DA oxidative intermediates, such as dihydroxyphenylacetic acid (DOPAC)
[8], dopaminochrome [12] and DHI [19] that have been suggested to play important roles in
promoting oligomerisation and preventing fibril formation. Moreover, the presence of anti-
Fig 2. Purification of DA:α-syn 43–140 soluble oligomers. Chromatogram of size exclusion chromatography of DA:α-syn 43–140 induced oligomers on a
Superdex 200 preparation grade column using 10 mM sodium phosphate pH 7.5 buffer with a flow rate of 1 mL/min. Proteins were detected at A280nm. Inset
shows silver stain SDS-PAGE of samples from the selected fractions (as denoted).
doi:10.1371/journal.pone.0116497.g002
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oxidants can prevent DA-mediated oligomer formation. [10, 19] We tested the ability of oxi-
dised DA to promote oligomerisation of the truncated proteins. Oxidised DA was produced by
incubating DA for 28 days in air, and the reaction was then centrifuged to obtain a pellet (cor-
responding to insoluble polymerised oxidised DA) and a supernatant (soluble oxidised DA)
fraction. The supernatant fractions were analysed by ESI-MS and an UV-visible absorbance
spectrum acquired between 200–700nm to confirm the absence of un-oxidised DA in the sam-
ple (data not shown). The truncated α-syn proteins were incubated with either the pellet or su-
pernatant oxidised DA fractions, or with freshly prepared DA and then analysed by SDS-
PAGE and silver staining (S1 Fig.). The soluble pre-oxidised DA was a much less effective in
promoting α-syn oligomerisation, while the insoluble pre-oxidised DA fraction was inactive.
This indicates that fully oxidized DA is significantly less effective in causing DA-mediated α-
syn oligomerisation and therefore we conclude the oxidation reaction and formation of oxida-
tive intermediates is required to drive this form of α-syn oligomerisation.
The DA:α-syn 43–140 dimer is predominantly random coil, even in the
presence of SDS
To study the biophysical properties of the DA:α-syn 43–140 species we reacted α-syn 43–140
with DA and the dimer and monomer were purified using SEC and their identity confirmed by
SDS-PAGE (Fig. 2) and ESI-Q-TOF mass spectrometry. The monomeric DA:α-syn 43–140
species isolated from the reaction mixture (Fig. 2, peak 3) had a mass of 10,372 Da a value con-
sistent with oxidation of the three methionine residues (expected mass 10,372 Da) [17] (there
are only two Mets in the native α-syn sequence, the N-terminal methionine is a plasmid-de-
rived residue). There was no evidence for a DA adduct on the DA:α-syn 43–140 monomer
under the conditions employed. The DA:α-syn 43–140 dimer (Fig. 2 peak 2) was analysed by
SELDI mass spectrometry and it had a mass of 20,855 Da. This mass does not correspond to
what is expected for an oxidised α-syn 43–140 dimer (20,744 Da), and we could not assign the
additional 111 Da to a specific modification or adduct indicating it’s not a “standard”modifica-
tion. Fraction 1 also showed the presence of a higher molecular weight species that may be a
trimer (Fig. 2, left most lane).
The DA:α-syn 43–140 dimer was characterised by far-UV CD spectroscopy and gave a sin-
gle minima at λ = 200 nm that is indicative of a predominately random coil structure. A similar
spectrum was observed for the DA:α-syn 43–140 monomer (Fig. 3A). Therefore, generation of
the DA:α-syn 43–140 dimer does not promote major secondary structure formation. In the
presence of SDS α-syn undergoes a conformational change from random coil to α-helix, with
the SDS-binding region reported to be in the N-terminus. [23, 34] The addition of SDS to the
DA:α-syn 43–140 monomer resulted in a distinctive 208/220 nm double minima, indicative of
α-helical structure (Fig. 3B). Therefore, the truncated N-terminus in 43–140 can still interact
with SDS and undergo a structural change, supporting the validity of the construct. In the ab-
sence of SDS, there was a reduction of the negative minimum at 200 nm for DA:α-syn 43–140
dimer (compare with the monomeric species) indicating a decrease in random coil content.
This observation is consistent with that of full length DA:α-syn oligomers. [26] The was no sig-
nificant difference in the secondary conformation of DA:α-syn 43–140 dimer in the absence
and presence od SDS (Fig. 3B). This result indicates the dimeric species is distinct from the
monomer species and has a reduced propensity to interact and/or be modified by SDS, and this
behaviour is consistent with the full-length 1–140 DA:α-syn dimer which can not interact with
lipid vesicles. [23]
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The DA:α-syn 43–140 dimer is highly stable
To investigate the stability of the DA:α-syn 43–140 dimer, we exposed it to trifluoroethanol
(TFE) and hexafluoroisopropanol (HFIP), which are known to dissociate oligomers to their
monomeric species. [35, 36] The DA:α-syn 43–140 dimer was incubated with HFIP (1%, 2%,
4%, 5%) and TFE (4%, 8%, 10%, 15%) for 18 hours at 37°C and then centrifuged at 100,000 rpm
Fig 3. SDS-dependent conformational transition in DA:α-syn 43–140monomer, but not DA:α-syn 43–140 dimer. Far UV CD spectrum of 15 μMDA:α-
syn 43–140 monomer or DA:α-syn 43–140 dimer in 10 mM sodium phosphate buffer, pH 7.5.A. DA:α-syn 43–140 monomer minus (thin line) or plus 16 mM
SDS (thick line). B. DA:α-syn 43–140 dimer minus (thin line) or plus 16 mM SDS (thick line). The CD spectrum shows the monomer and dimer in the absence
of SDS have an intensity at λ = 200 nm is indicative of random coil structure. [58] In the presence of SDS, the α-syn 43–140 monomer, but not the α-syn 43–
140 dimer, showed a double minima at 208 and 220 nm with a maximum at 190nm are indicative of α-helical content. [59]
doi:10.1371/journal.pone.0116497.g003
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(1 hour, 4°C) to isolate the soluble supernatant fraction. The supernatant was analysed by SDS-
PAGE and silver staining. The DA:α-syn 43–140 dimers did not dissociate under any of these
conditions (Fig. 4). Therefore, the DA:α-syn 43–140 dimers are highly stable and resistant to
conventional dissociation methods.
α-syn 43–140 binds three DA ligands in the extended state conformation
To further analyse the conformational properties of the DA:α-syn 43–140 protein we employed
electrospray ionisation—ion mobility—mass spectrometry (ESI-IMS-MS). This method allows
the gross conformation state and non-covalent interactions of a protein to be determined. [37,
38] The charge state distribution observed post-ionisation reflects the solution state of the pro-
tein in question. [39, 40] Folded or conformationally collapsed proteins typically obtain narrow
charge state distributions with shortened drift times, whereas unfolded or extended proteins
obtain wide charge state distributions with longer drift times. [41] Under neutral conditions
full length α-syn can populate multiple extended conformational states (charge state ions +8
to +18) as well as a sub population of more compact conformational states (charge state ions +6
to +8). In the presence of DA, three DA ligands bind exclusively to a highly extended state
(charge state ions +11 to +17) while the +10 charge state ion bound only a single DA ligand. The
subsequent oxidised form of the protein is only observed on incubation. [25] ESI-IMS-MS analy-
sis of monomeric α-syn 43–140 in the presence or absence of DA also populated both extended
and compact conformations under neutral conditions similar to the full length protein (Fig. 5A).
Fig 4. Stability of DA:α-syn 43–140 dimer exposed to denaturants. Silver stain SDS-PAGE gel of DA:α-syn 43–140 dimer incubated with different
amounts of denaturants HFIP or TFE. The dimers did not dissociate under any of the conditions tested, suggesting a covalent cross-link. Lane 1: DA:α-syn
43–140 dimer + 1% HFIP. Lane 2: DA:α-syn 43–140 dimer + 2% HFIP. Lane 3: DA:α-syn 43–140 dimer + 4% HFIP. Lane 4: DA:α-syn 43–140 dimer + 5%
HFIP. Lane 5: DA:α-syn 43–140 dimer + 4% TFE. Lane 6: DA:α-syn 43–140 dimer + 8% TFE. Lane 7: DA:α-syn 43–140 dimer + 10% TFE. Lane 8: DA:α-
syn 43–140 dimer + 15% TFE. Arrow indicates the DA:α-syn 43–140 dimer band.
doi:10.1371/journal.pone.0116497.g004
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The extended state displayed a wide charge state distribution (+13 to +6 charge state ions) with
extended drift times, whereas the compact state displayed a narrow charge state distribution (+7
to +5 charge state ions) with shortened drift times. The +7 and +6 charge state ions are co-popu-
lated by both conformational series with the most extended states being observed at the longer
drift times. Similar to full length α-syn in the presence of DA, the highly extended charge state
Fig 5. Driftscope plots of α-syn 43–140 with or without further addition of DA. The x axis represents drift time (msec), on the y axism/z is shown; peak
intensity is displayed on a square root scale. Corresponding mass spectrum for each acquisition is overlaid on the right of each Driftscope plot, indicating
charge states and the presence or absence of the DA ligands is by the number of black dots.A. 40 μM α-syn 43–140 in the absence of DA. B. 40 μM α-syn
43–140 in the presence of DA. The asterisks refer to the number of DA molecules bound.
doi:10.1371/journal.pone.0116497.g005
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ions +13 to +8 of α-syn 43–140 also bound up to three DA ligands and the less extended charge
state ions (+8 to +6) bound a single DA (Fig. 5B, arrows). The most compact states populated at
the +7 to +5 charge state ions remained ligand free. The behaviour of α-syn 43–140 mirrored
that previously observed for full-length α-syn in that the three DA ligands bind to the high
charge state ions of the extended conformation without the requirement to first oxidise the Met
residues. [25] The dimeric species was not amenable to ESI-IMS-MS.
NMR analysis of the DA:α-syn 43–140 monomer and dimer
To analyse the behaviour and structure of the DA:α-syn 43–140 oligomers in solution we stud-
ied DA:α-syn 43–140 using NMR. This protein construct was chosen to reduce the spectral
complexity arising from the presence of multiple repeat sequence motifs in α-syn and the resul-
tant chemical shift redundancy.
Sequence specific NMR resonance assignments were determined for DA:α-syn 43–140
monomer and dimer using a set of spectra acquired on either singly (15N) or doubly (15N, 13C)
labelled protein (refer Methods). A proton nitrogen correlation spectrum (1H, 15N-HSQC) of
the DA:α-syn 43–140 monomer was recorded at pH 5.5 to ensure favourable amide proton ex-
change rates. The 1H, 15N-HSQC spectrum of the DA:α-syn 43–140 monomer displayed the
characteristic narrow chemical shift dispersion in the amide 1H resonances for an IDP [42], of
about 1 ppm (Fig. 6). [43, 44] The resonance assignments were consistent with those reported
previously for α-syn. [45, 46] Similar to α-syn 43–140, the 1H, 15NHSQC spectrum of DA:α-
syn 43–140 dimer also showed the characteristic lack of chemical shift dispersion for the amide
1H resonances expected for an IDP (Fig. 6). This indicates that like the monomer the DA:α-syn
43–140 dimer is essentially unstructured in solution and this finding is consistent with the CD
data (Fig. 3).
Resonance positions in NMR are highly sensitive to nuclear electronic environment and
changes in chemical shift positions can indicate changes in conformation, for example, the Cα
chemical shift in proteins, is dependent on the φ,ψ backbone torsion angles and indicative of
secondary structure. [47] Monitoring changes in chemical shifts may indicate conformational
change. Overlaying the 1H, 15NHSQC spectra of DA:α-syn 43–140 dimer and monomer iden-
tified 13 resonances that were shifted or broadened in the spectra of the DA:α-syn 43–140
dimer compared to those in the monomer, while the rest of the resonances were less affected.
The residues with the more significant chemical amide chemical shift differences were: T43,
V48, V49, H50, G51, T59, K60, L113, E114, M116, V118, E126, M127, and S129 (indicated
with  in Fig. 6). Resonances of residues V48, V49, H50, K60 (indicated with an orange  in
Fig. 6) were weakened in intensity in the spectra of the DA:α-syn 43–140 dimer but not shifted
significantly from the position in the monomer and suggest an exchange broadening process is
occurring for these residues in the dimer. The near-identical chemical shifts observed for the
majority of amide resonances between monomer and dimer is consistent with a high degree of
structural similarity between them. This suggests a very limited intermolecular interface for
DA:α-syn 43–140 dimer that is confined to only the few residues involved in a putative cross-
link. Further analysis of chemical shift for the Hα, C’ and Cα resonances, that are sensitive to
backbone conformation [47], of the DA:α-syn 43–140 dimer showed they only had minor devi-
ations from their expected random coil positions for, again further confirmation of the lack of
regular secondary structure observed for this protein (Fig. 7A and 7B). The difference between
the Cα chemical shifts of the DA:α-syn 43–140 monomer and dimer were plotted to determine
any potential changes in conformation following dimer formation. Little difference was ob-
served in the Cα chemical shift positions between the monomer and dimer, indicating that the
formation of the dimer maintains the overall random coil conformation of the monomer
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Fig 6. Comparison of 1H, 15N-HSQC spectra acquired on DA:α-syn 43–140monomer and α-DA:syn 43–140 dimer showing the characteristics
expected for an intrinsically disorder protein. The proton-nitrogen correlation spectrum (HSQC) of 0.5 mM DA:α-syn 43–140 monomer or DA:α-syn 43–
140 dimer in 10 mM sodium phosphate buffer, pH5.5. Spectra were acquired at 5°C and 800MHz. The HSQC spectrum of DA:α-syn 43–140 monomer is
depicted in black and the DA:α-syn 43–140 dimer in pink. Amide resonance assignments are indicated for the DA:α-syn 43–140 monomer as sequence
position and the poor chemical shift dispersion indicates little if any secondary structure is present. * indicate residues of interest, those colored orange
indicate resonances with exchange broadening (see the text).
doi:10.1371/journal.pone.0116497.g006
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Fig 7. Chemical shift deviations between DA:α-syn 43–140monomer and DA:α-syn 43–140 dimer. The
Cα resonances (Panels A and B) of the DA:α-syn 43–140 dimer do not differ significantly from those of the
DA:α-syn 43–140 monomer.A. Cα chemical shift deviations from random coil values predict that the DA:α-
syn 43–140 monomer is largely unstructured. B. Plot of chemical shift difference for Cα chemical shifts
between DA:α-syn 43–140 monomer and DA:α-syn 43–140 dimer. The chemical shift deviation is plotted
in ppm as a function of residue position in DA:α-syn 43–140 monomer. C. Plot of difference in Cα resonance
position (ΔδCα (ppm)) from random coil values [60] for DA:α-syn 43–140 monomer. The largest differences
arise from residues preceding a proline (A107, M116, D119, M127, E138). D. Plot of difference in Cα
resonance positions between DA:α-syn 43–140 monomer and DA:α-syn 43–140 dimer (δdimer—δmonomer).
The absence of significant chemical shift differences between the DA:α-syn 43–140 dimer and DA:α-syn 43–
140 monomer indicates their structural similarity. The largest differences are localised to residues near the
methionine residues (M116, M127) that are likely to be oxidised under the conditions of DA-mediated α-syn
43–140 dimer formation.
doi:10.1371/journal.pone.0116497.g007
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(Fig. 7C and 7D). The largest differences in chemical shift are located in the vicinity of the me-
thionines (M116, M127) and likely due to the methionine oxidation. [17]
Trypsin digestion of the DA:α-syn 43–140 dimer
To elucidate potential modifications/adducts mediated by DA the DA:α-syn 43–140 monomer
and dimer proteins were trypsin digested and analysed by mass spectrometry. Trypsin digested
DA:α-syn 43–140 monomer gave a mass at 1478.4 Da (corresponding to a fragment encom-
passing residues 81 to 95, Fig. 8A). Another fragment was observed at m/z 1295.4 Da corre-
sponding to residues 46 to 58. The smaller fragments at 247 Da, 146 Da and 559 Da were
indistinguishable from the masses of the buffer salts and DA and could not be unequivocally
identified. The mass spectrum of trypsin digested DA:α-syn 43–140 dimer showed a major
mass at 1478.4 Da corresponding to residues 81 to 95. However, the 46 to 58 fragment (mass of
1295.4 Da) present in the DA:43–140 monomer digest was absent (Fig. 8B). The absence of
this species suggests this fragment contains residues that have been modified in the formation
of the dimer. However, we did not detect the appearance of a corresponding new mass. The
modification could have resulted in inhibition/alteration of the trypsin cleavage site or the crea-
tion of a much larger, but undetected fragment, or it may not have ionised.
His50, Glu83, and the NAC region are not necessary for DA-mediated
oligomerisation, but the NAC region is required for formation of discrete
oligomeric species
The formation of DA:α-syn soluble oligomers is presumed to require an oxidative reaction [10,
12, 17, 19], since the methionine residues in α-syn are oxidised by DA and methionine-less α-
syn mutant does not form soluble oligomers. [17] Histidine is another residue that is prone to
oxidative modification [48, 49] and α-syn has a single histidine residue at position 50 (H50)
which is in the proposed 43–60 interface region. H50 was mutated to asparagine (H50N) and
tested for its ability to undergo DA-mediated oligomerisation. α-syn 43–140:H50N formed
DA-mediated soluble oligomers similar to wildtype α-syn 43–140 (Fig. 9), therefore, His50 is
not critical for DA-mediated oligomerisation. A previous report had implicated E83 to be nec-
essary for DA-mediated α-syn fibrillisation. [28] We tested the role of E83 in our system by in-
cubating the α-syn 43–140 E83A mutant with DA. The α-syn 43–140 E83A was capable of
forming DA-mediated soluble oligomers similar to those formed by α-syn 43–140 (Fig. 9) indi-
cating E83 is not necessary for DA-mediated oligomerisation of α-syn 43–140.
The NMR data acquired on DA:α-syn 43–140 suggests that residues in the region 43–60 are
potentially involved in the formation of the DA:α-syn soluble dimers. To examine this, we test-
ed whether DA could induce oligomerisation of a peptide that spans residues 43–60 of α-syn.
We analysed the reaction by Tricine SDS-PAGE which is better suited for separating small mo-
lecular peptides. [50] Incubation of α-syn 43–60 with DA did not induce soluble oligomers, as
detected by Tricine SDS-PAGE and silver staining (Fig. 10A), suggesting sequences outside, or
in addition to, residues 43–60 are required for oligomer formation. We also analysed the reac-
tion by both MALDI and electrospray mass spectrometry and the only species detected was the
monomeric peptides, and no higher molecular weight species were detected (data not shown).
To test if the NAC fragment was necessary for DA-mediated oligomerisation, we examined the
behaviour of α-syn 1–60 which represents a NAC-deleted species. α-syn 1–60 formed soluble
oligomers after treatment with DA and in a dose dependent manner. However, this species did
not migrate as a discrete band typically seen for α-syn 43–140 (Fig. 10B). We used SEC to de-
termine how the DA:α-syn 1–60 species migrated in solution as compared to α-syn 43–140.
Consistent with the SDS-PAGE data the DA:α-syn 1–60 and DA:α-syn 43–140 had distinct
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profiles with DA:α-syn 43–140 displaying multiple distinct peaks while DA:α-syn 1–60 showed
only a single major peak and lacked distinct species in the region between 10–15 mL in the elu-
tion profile. (Fig. 10C).
The hydrophobic NAC region (residues 60–95) abuts 43–60 and is required for α-syn fibril-
lisation. A proline scan of this region identified residues that inhibited fibril formation, such as
threonine 75. [51] To examine the role of the NAC region in DA-mediated oligomerisation we
tested the α-syn 43–140 T75P mutant and found it formed DA-mediated SDS-stable soluble
Fig 8. Differences between trypsin treatment of DA:α-syn 43–140monomer and dimer. A. Mass spectrum of the DA:α-syn 43–140 monomer after
overnight digestion at 37°C by trypsin. A major mass at 1478.4 Da was observed corresponding to residues 81 to 95, while a mass at 1295.4 Da is consistent
with a fragment between residues 46 to 58.B. Trypsin cleaves the DA:α-syn 43–140 dimer into a single detectable fragment. Mass spectrum of the trypsin
digest of the DA:α-syn 43–140 dimer reveals a single peak of mass 1478.4 Da, and the absence (broken line box) of the 1295.4 Da fragment formed by the
DA:α-syn 43–140 monomer digest. This suggests this fragment is potentially modified upon interaction with DA.
doi:10.1371/journal.pone.0116497.g008
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oligomers in a dose-dependent manner (Fig. 11). Therefore, while the NAC region is not re-
quired for oligomerisation, it is necessary for ensuring discrete oligomeric species are generated
and there are potentially multiple mechanisms for oligomerisation.
DISCUSSION
The N-terminally truncated 43–140 α-syn dimer was chosen for structural characterisation,
over the C-terminal truncation or full-length α-syn, as α-syn 43–140 formed DA-mediated sol-
uble oligomers with a similar oligomeric pattern to full length α-syn but significantly simplified
the NMR analysis by reducing the number of sequence repeats to minimize chemical shift re-
dundancy in the spectra. Moreover, the ESI-IMS-MS analysis of 43–140 α-syn showed it be-
haved in a similar manner to full-length α-syn by occupying both extended and compact
conformations under neutral conditions. In the presence of DA the highly extended state mo-
nomeric state bound three DA ligands without the need to oxidise the Met residues. These sim-
ilarities between 43–140 and full-length α-syn support the utility of using the 43–140 construct
to investigate which regions of α-syn are required for the formation of the DA-mediated oligo-
mers. In this study we compared the monomeric and dimeric species in order to understand
the mechanism by which DA mediates α-syn oligomerisation.
Fig 9. α-syn point mutants form oligomers. Silver stain SDS-PAGE gel of soluble fraction of mutant α-syn
reacted with DA. Lane 1: α-syn 43–140, Lane 2: α-syn 43–140 + DA (1:10), Lane 3: α-syn 43–140 E83A,
Lane 4: α-syn 43–140 E83A + DA (1:10), Lane 5: α-syn 43–140 H50N, Lane 6: α-syn 43–140 H50N+ DA
(1:10)
doi:10.1371/journal.pone.0116497.g009
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CD and NMR spectra showed the DA:α-syn 43–140 dimer adopted a largely unstructured
conformation in solution. The 1H, 15NHSQC spectrum showed amide resonances with limited
chemical shift dispersion, characteristic of an IDP [52], while CD spectra had a single mini-
mum of negative ellipticity at 200 nm and negligible ellipticity at 220 nm, again indicative of an
IDP [53] The majority of amide resonances in the 1H,15NHSQC of α-syn 43–140 dimer were
unshifted compared with those in the monomer, indicating that there is not a gross conforma-
tional change when compared to the monomer. Amide resonances of T43, V48, V49, H50,
G51, T59, K60, E114, M116, V118, E126, M127, and S129 for the α-syn 43–140 dimer, are
shifted or broadened compared to those in the monomer. These changes are centred around
the N-terminus and the M127 residue at the C-terminus and indicates changes in chemical en-
vironment surrounding specific residues upon interaction with DA. Furthermore, the similari-
ty in the 1H,15N-HSQC spectra between the dimer and monomer α-syn 43–140 suggests that,
only a limited number of residues are modified by DA.
While CD, NMR and mass spectrometry data identified very few differences between the
DA:α-syn 43–140 dimer and monomer, the dimer displayed altered behaviour in a membrane-
mimetic environment. The presence of SDS caused α-syn 43–140 monomer to adopt α-helical
structures and similar behaviour has been observed for full length α-syn. [45, 54–56] It is inter-
esting to note that this occurs even without the first 42 residues of α-syn, which are a key part
of the α-helical region. [34] Presumably, the stretch between residues 43 to 60, just after the
purported break in the α-helical region, is sufficient for the initiation of α-helical formation in
Fig 10. Truncationmutants of α-syn form oligomers after treatment with DA. Truncated α-syn and mutants were treated with DA and the soluble fraction
subjected to SDS-PAGE and visualised by silver stainingA. Tricine SDS-PAGE. Lane 1: α-syn 43–140, Lane 2: α-syn 43–140 + DA, Lane 3: α-syn 43–60,
Lane 4: α-syn 43–60 + DA. B. Lane 1: α-syn 43–140, Lane 2: α-syn 43–140 + DA (1:4), Lane 3: α-syn 43–140 + DA (1:10), Lane 4: α-syn 1–60, Lane 5: α-syn
1–60 + DA (1:4), Lane 6: α-syn 1–60 + DA (1:10).C. SEC of the α-syn 43–140 and α-syn 1–60 DA induced oligomers. 200 μM α-syn was incubated with
2 mMDA for 7 days. The reaction was centrifuged at 100,000 rpm, 1 hour, 4°C and then analysed on a Superdex 200 10/300GL column using 10 mM sodium
phosphate pH 7.5 buffer with a flow rate of 0.5 mL/min. Proteins were detected at A280nm. The solid line represents α-syn 43–140 and broken line α-syn
1–60.
doi:10.1371/journal.pone.0116497.g010
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the presence of SDS [56] and consistent with our observation that residues 58–60 are the most
affected, apart from those that are close to methionine, by DA.We have shown that lipids inhibit
the formation of DA:α-syn oligomers, while the DA:α-syn oligomer cannot interact with lipid vesi-
cles or cause membrane permeability. [23] In the current study, the observation that DA:α-syn
43–140 dimer did not form α-helices in the presence of SDS, is consistent with residues 43 to 60
being modified in dimer formation. Support for residues 43 to 60 being involved in the formation
of soluble oligomers came from the trypsin digestion analysis of the DA:α-syn 43–140 dimer.
Mass spectrometry of the trypsin generated fragments showed that the fragment corresponding
to residues 46 to 58 was not detected following digestion of DA:α-syn 43–140 dimer (again consis-
tent with the 58–60 region). This indicated potential modification in this region en route to the
formation of the dimer. However, no corresponding newmass fragments were detected and there-
fore the identity of the modification remains unresolved. The importance of residues 43–60 was
highlighted by α-syn 1–60 being capable of forming SDS-stable soluble oligomers in a dose depen-
dent manner, with an oligomeric profile similar to that of DA:α-syn 43–140 and full length DA:α-
syn. The α-syn 1–60 construct lacks the NAC region (61–95) and its ability to form oligomers
confirms the NAC region is not necessary for playing a significant role in oligomer formation.
Fig 11. The NAC region is not required for DAmediated oligomerisation. The NAC fibrillsation mutant
T75P did not alter DA mediated oligomerisation of α-syn 43–140. α-syn 43–140 T75P was incubate with
different ratios of DA from 1:1 to 1:20 and analysed by SDS-PAGE and silver stain. Lane 1: α-syn 43–140
T75P, Lane 2: α-syn 43–140 T75P + DA (1:1), Lane 3: α-syn 43–140 T75P + DA (1:2), Lane 4: α-syn 43–140
T75P + DA (1:5), Lane 5: α-syn 43–140 T75P + DA (1:10), Lane 6: α-syn 43–140 T75P + DA (1:20), Lane 7:
α-syn 43–140, Lane 8: α-syn 43–140 + DA (1:10)
doi:10.1371/journal.pone.0116497.g011
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Our studies expand upon the NMR and biophysical analysis of full length α-syn modified by
DA quinones [16] which showed the modified α-syn retained its unfolded conformation. Of par-
ticular relevance to our study is that only a small number of α-syn molecules were covalently
modified by the DA quinones. [16] This may explain our inability to detect the covalent modifi-
cation keeping the α-syn dimer together. The lack of major differences being observed in the
NMR and CD spectra on treatment of α-syn 43–140 with DA suggests the interface of dimerisa-
tion or any structured core region is small. Only a few residues between 43 to 60 are involved
(T43, V48, V49, H50, G51, T59, K60), potentially via lysine residue modifications, while the rest
of the protein remains disordered in solution. Interestingly, the N-terminal region of α-syn, be-
tween residues 1–60, was found to be important for the binding of exifone, an inhibitor of α-syn
aggregation adding weight that this region modulates α-syn aggregation. [57] Our NMR analysis
implicated a role for the C2 of His50, however, the α-syn 43–140 H50Nmutant could still form
oligomers in the presence of DA. This suggests that the histidine residue is not solely responsible
for the formation of oligomers and that other residues in α-syn 43–140 may also be involved, or
that other residues may assume the role of His50 in the H50Nmutant. While α-syn E83A was
proposed to abolish the ability of DA to inhibit α-syn fibrillisation. [28], in our hands α-syn 43–
140 E83A could form DA-mediated soluble oligomers. This supports the model where the path-
way towards formation of DA-mediated soluble oligomers is distinct to that of α-syn fibrillisa-
tion. While the T75Pmutant in the NAC region was also ineffective in altering DA-mediated α-
syn oligomerisation and it may point to multiple mechanisms for dimer formation.
This study has provided novel and important data on the structural characteristics of the DA:α-
syn oligomer, and the contribution of distinct domains and residues to their formation. We have
narrowed the interface to a small region and while the exact residues involved and the nature
of the interaction with DA / DA-products remains unresolved, our new data further defines the
mechanism by which DAmediates the formation of these SDS-stable soluble DA:α-syn oligomers.
Supporting Information
S1 Fig. Oligomerisation of α-syn treated with pre-oxidised DA. Silver stained SDS-PAGE
gel of the different α-syn proteins treated with either freshly prepared or pre-oxidised DA. No
DA refers to the proteins minus the addition DA. Fresh DA refers to DA (200uM) that has
been added to the α-syn soon after the DA has been dissolved, as per the other incubations per-
formed in this study, i.e. Fig. 1B. Oxidised DA supernatant is the supernatant fraction of the
28 day reacted DA; Oxidised DA is the pellet fraction of the 28 day reacted DA that was then
resuspended into water. DA ctl, oxDA supernatant and oxDA pellet is the reaction with just
the specific DA species indicated but minus α-syn, in order to show what staining is due to the
DA. The α-syn to DA ratio was 1:10.
(TIF)
Author Contributions
Conceived and designed the experiments: SLL KJB RC. Performed the experiments: SLL ARC
DPS EIT CLLP. Analyzed the data: SLL ARCMGHDPS EIT CLLP KJB RC. Contributed re-
agents/materials/analysis tools: SLL MGH DPS CLLP RC. Wrote the paper: SLL ARCMGH
DPS EIT CLLP KJB RC.
References
1. Hatano T, Kubo S, Sato S, Hattori N (2009) Pathogenesis of familial Parkinson's disease: new insights
based on monogenic forms of Parkinson's disease. J Neurochem 111: 1075–1093. doi: 10.1111/j.
1471-4159.2009.06403.x PMID: 19780902
Interface for Dopamine Mediated α-Synuclein Dimerisation
PLOS ONE | DOI:10.1371/journal.pone.0116497 February 13, 2015 20 / 23
2. Kahle PJ, Haass C, Kretzschmar HA, Neumann M (2002) Structure/function of alpha-synuclein in
health and disease: rational development of animal models for Parkinson's and related diseases. J
Neurochem 82: 449–457. PMID: 12153470
3. Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, et al. (2013) Oxidative and nitrative
alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and inter-
ventions in synucleinopathies. J Neurochem 125: 491–511. doi: 10.1111/jnc.12226 PMID: 23452040
4. Breydo L, Wu JW, Uversky VN (2012) Alpha-synuclein misfolding and Parkinson's disease. Biochim
Biophys Acta 1822: 261–285. doi: 10.1016/j.bbadis.2011.10.002 PMID: 22024360
5. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, et al. (1993) Molecular cloning of cDNA encoding an
unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 90: 11282–
11286. PMID: 8248242
6. Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the
nucleus and presynaptic nerve terminal. J Neurosci 8: 2804–2815. PMID: 3411354
7. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, HoWH, et al. (2000) Mice lacking alpha-synuclein
display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239–252. PMID: 10707987
8. Mazzulli JR, Armakola M, Dumoulin M, Parastatidis I, Ischiropoulos H (2007) Cellular oligomerization of
alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence. J
Biol Chem 282: 31621–31630. PMID: 17785456
9. Jain MK, Bhat R. (2014) Modulation of human α-synuclein aggregation by a combined effect of calcium
and dopamine. Neurobiol Dis. 63:115–128. doi: 10.1016/j.nbd.2013.11.004 PMID: 24269918
10. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synu-
clein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346–1349. PMID: 11701929
11. Li J, Zhu M, Manning-Bog AB, Di Monte DA, Fink AL (2004) Dopamine and L-dopa disaggregate amy-
loid fibrils: implications for Parkinson's and Alzheimer's disease. FASEB J 18: 962–964. PMID:
15059976
12. Norris EH, Giasson BI, Hodara R, Xu S, Trojanowski JQ, et al. (2005) Reversible inhibition of alpha-
synuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem 280:
21212–21219. PMID: 15817478
13. Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, et al. (2005) Dopamine promotes alpha-synu-
clein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J 19:
1377–1379. PMID: 15946991
14. Ito S, Nakaso K, Imamura K, Takeshima T, Nakashima K (2010) Endogenous catecholamine enhances
the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overex-
pressing human alpha-synuclein. Neurosci Res 66: 124–130. doi: 10.1016/j.neures.2009.10.005
PMID: 19835916
15. Yamakawa K, Izumi Y, Takeuchi H, Yamamoto N, Kume T, et al. (2010) Dopamine facilitates alpha-
synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun
391: 129–134. doi: 10.1016/j.bbrc.2009.11.015 PMID: 19900407
16. Bisaglia M, Tosatto L, Munari F, Tessari I, de Laureto PP, et al. (2010) Dopamine quinones interact with
alpha-synuclein to form unstructured adducts. Biochem Biophys Res Commun 394: 424–428. doi: 10.
1016/j.bbrc.2010.03.044 PMID: 20226175
17. Leong SL, Pham CL, Galatis D, Fodero-Tavoletti MT, Perez K, et al. (2009) Formation of dopamine-me-
diated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radic Biol Med 46:
1328–1337. doi: 10.1016/j.freeradbiomed.2009.02.009 PMID: 19248830
18. Hokenson MJ, Uversky VN, Goers J, Yamin G, Munishkina LA, et al. (2004) Role of individual methio-
nines in the fibrillation of methionine-oxidized alpha-synuclein. Biochemistry 43: 4621–4633. PMID:
15078109
19. Pham CL, Leong SL, Ali FE, Kenche VB, Hill AF, et al. (2009) Dopamine and the dopamine oxidation
product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synu-
clein in a pH-dependent manner. J Mol Biol 387: 771–785. doi: 10.1016/j.jmb.2009.02.007 PMID:
19361420
20. Segura-Aguilar J, Paris I, Munoz P, Ferrari E, Zecca L, et al. (2014) Protective and toxic roles of dopa-
mine in Parkinson's disease. J Neurochem 129: 898–915. doi: 10.1111/jnc.12686 PMID: 24548101
21. Bisaglia M, Mammi S, Bubacco L (2007) Kinetic and structural analysis of the early oxidation products
of dopamine: analysis of the interactions with alpha-synuclein. J Biol Chem 282: 15597–15605. PMID:
17395592
22. Pham CL, Kirby N, Wood K, Ryan T, Roberts B, et al. (2014) Guanidine hydrochloride denaturation of
dopamine-induced alpha-synuclein oligomers: A small-angle X-ray scattering study. Proteins 82: 10–
21. doi: 10.1002/prot.24332 PMID: 23733394
Interface for Dopamine Mediated α-Synuclein Dimerisation
PLOS ONE | DOI:10.1371/journal.pone.0116497 February 13, 2015 21 / 23
23. Pham CLL, Cappai R (2013) The interplay between lipids and dopamine on alpha-synuclein oligomeri-
zation and membrane binding. Bioscience Rep 33: 807–814.
24. Planchard MS, Exley SE, Morgan SE, Rangachari V (2014) Dopamine-induced alpha-synuclein oligo-
mers show self- and cross-propagation properties. Protein Sci 23: 1369–1379. doi: 10.1002/pro.2521
PMID: 25044276
25. Illes-Toth E, Dalton CF, Smith DP (2013) Binding of Dopamine to Alpha-Synuclein is Mediated by Spe-
cific Conformational States. J Am Soc Mass Spectr 24: 1346–1354. doi: 10.1007/s13361-013-0676-z
PMID: 23817832
26. Rekas A, Knott RB, Sokolova A, Barnham KJ, Perez KA, et al. (2010) The structure of dopamine in-
duced alpha-synuclein oligomers. Eur Biophys J 39: 1407–1419. doi: 10.1007/s00249-010-0595-x
PMID: 20309679
27. Zijlstra N, Claessens MM, Blum C, Subramaniam V (2014) Elucidating the aggregation number of dopa-
mine-induced alpha-synuclein oligomeric assemblies. Biophys J 106: 440–446. doi: 10.1016/j.bpj.
2013.12.009 PMID: 24461019
28. Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, et al. (2008) Inhibition of alpha-synuclein
fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the
NAC region. PLoS One 3: e3394. doi: 10.1371/journal.pone.0003394 PMID: 18852892
29. Marley J, Lu M, Bracken C (2001) A method for efficient isotopic labeling of recombinant proteins. J Bio-
mol NMR 20: 71–75. PMID: 11430757
30. Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the
structure determination of proteins in solution employing pulsed field gradients. Prog Nucl Mag Res Sp
34: 93–158.
31. Piotto M, Saudek V, Sklenář V (1992) Gradient-tailored excitation for single-quantum NMR spectrosco-
py of aqueous solutions. J Biomol NMR 2: 661–665. PMID: 1490109
32. Keller R (2004) The Computer Aided Resonance Assignment Tutorial. Goldau Switzerland CANTINA
Verlag. PMID: 25057686
33. Palmer AG, Cavanagh J, Wright PE, Rance M (1991) Sensitivity improvement in proton-detected two-
dimensional heteronuclear correlation NMR spectroscopy. J Magn Reson 93: 151–170.
34. DavidsonWS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary
structure upon binding to synthetic membranes. J Biol Chem 273: 9443–9449. PMID: 9545270
35. Hirota-Nakaoka N, Hasegawa K, Naiki H, Goto Y (2003) Dissolution of beta2-microglobulin amyloid fi-
brils by dimethylsulfoxide. J Biochem 134: 159–164. PMID: 12944383
36. MacPhee CE, Dobson CM (2000) Chemical dissection and reassembly of amyloid fibrils formed by a
peptide fragment of transthyretin. J Mol Biol 297: 1203–1215. PMID: 10764584
37. Jurneczko E, Barran PE (2011) How useful is ion mobility mass spectrometry for structural biology?
The relationship between protein crystal structures and their collision cross sections in the gas phase.
Analyst 136: 20–28. doi: 10.1039/c0an00373e PMID: 20820495
38. Woods LA, Radford SE, Ashcroft AE (2013) Advances in ion mobility spectrometry-mass spectrometry
reveal key insights into amyloid assembly. Biochim Biophys Acta 1834: 1257–1268. doi: 10.1016/j.
bbapap.2012.10.002 PMID: 23063533
39. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989) Electrospray ionization for mass spec-
trometry of large biomolecules. Science 246: 64–71. PMID: 2675315
40. Kaltashov IA, Mohimen A (2005) Estimates of protein surface areas in solution by electrospray ioniza-
tion mass spectrometry. Anal Chem 77: 5370–5379. PMID: 16097782
41. Smith DP, Giles K, Bateman RH, Radford SE, Ashcroft AE (2007) Monitoring copopulated conforma-
tional states during protein folding events using electrospray ionization-ion mobility spectrometry-mass
spectrometry. J Am Soc Mass Spectrom 18: 2180–2190. PMID: 17964800
42. Grzesiek S, Bax A (1992) Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein. J
Magn Reson 96: 432–440.
43. Clubb RT, Thanabal V, Wagner G (1992) A constant-time three-dimensional triple-resonance pulse
scheme to correlate intraresidue 1HN, 15N, and 13C' chemical shifts in 15N—13C-labelled proteins. J
Magn Reson 97: 213–217.
44. Dyson HJ, Wright PE (2002) Insights into the structure and dynamics of unfolded proteins from nuclear
magnetic resonance. Adv Protein Chem 62: 311–340. PMID: 12418108
45. Eliezer D, Kutluay E, Bussell R, Jr., Browne G (2001) Conformational properties of alpha-synuclein in
its free and lipid-associated states. J Mol Biol 307: 1061–1073. PMID: 11286556
Interface for Dopamine Mediated α-Synuclein Dimerisation
PLOS ONE | DOI:10.1371/journal.pone.0116497 February 13, 2015 22 / 23
46. Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM (2005) Mapping long-
range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simula-
tions. J Am Chem Soc 127: 476–477. PMID: 15643843
47. Wishart DS, Sykes BD, Richards FM (1992) The chemical shift index: a fast and simple method for the
assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31: 1647–1651.
PMID: 1737021
48. Bae EJ, Ho DH, Park E, Jung JW, Cho K, et al. (2013) Lipid Peroxidation Product 4-Hydroxy-2-Nonenal
Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of alpha-Synuclein. Antioxid
Redox Sign 18: 770–783. doi: 10.1089/ars.2011.4429 PMID: 22867050
49. Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, et al. (2005) Structural characterization of
copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.
Proc Natl Acad Sci U S A 102: 4294–4299. PMID: 15767574
50. Schagger H, von JagowG (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis
for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368–379. PMID:
2449095
51. Koo HJ, Lee HJ, Im H (2008) Sequence determinants regulating fibrillation of human alpha-synuclein.
Biochem Biophys Res Commun 368: 772–778. doi: 10.1016/j.bbrc.2008.01.140 PMID: 18261982
52. Dyson HJ, Wright PE (2004) Unfolded proteins and protein folding studied by NMR. Chem Rev 104:
3607–3622. PMID: 15303830
53. Receveur-Brechot V, Bourhis JM, Uversky VN, Canard B, Longhi S (2006) Assessing protein disorder
and induced folding. Proteins 62: 24–45. PMID: 16287116
54. Bisaglia M, Tessari I, Pinato L, Bellanda M, Giraudo S, et al. (2005) A topological model of the interac-
tion between alpha-synuclein and sodium dodecyl sulfate micelles. Biochemistry 44: 329–339. PMID:
15628875
55. Bussell R Jr., Eliezer D (2003) A structural and functional role for 11-mer repeats in alpha-synuclein
and other exchangeable lipid binding proteins. J Mol Biol 329: 763–778. PMID: 12787676
56. Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC (2003) A broken alpha -helix in folded alpha -Synuclein.
J Biol Chem 278: 15313–15318. PMID: 12586824
57. Yamaguchi Y, Masuda M, Sasakawa H, Nonaka T, Hanashima S, et al. (2010) Characterization of In-
hibitor-Bound alpha-Synuclein Dimer: Role of alpha-Synuclein N-Terminal Region in Dimerization and
Inhibitor Binding. J Mol Biol 395: 445–456. doi: 10.1016/j.jmb.2009.10.068 PMID: 19895818
58. Uversky VN (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11:
739–756. PMID: 11910019
59. Sreerama N, Woody RW (2004) Computation and analysis of protein circular dichroism spectra. Meth-
ods Enzymol 383: 318–351. PMID: 15063656
60. Kjaergaard M, Poulsen FM (2012) Disordered proteins studied by chemical shifts. Prog Nucl Magn
Reson Spectrosc 60: 42–51. doi: 10.1016/j.pnmrs.2011.10.001 PMID: 22293398
Interface for Dopamine Mediated α-Synuclein Dimerisation
PLOS ONE | DOI:10.1371/journal.pone.0116497 February 13, 2015 23 / 23
